Nolevaux G, Bessaci-Kabouya K, Villenet N, et al. Epidemiological and clinical study of Mycoplasma pneumoniae respiratory infections in children hospitalized in a pediatric ward between 1999 and 2005 at the Reims University Hospital[J]. Arch Pediatr, 2008,15(11):1630-1636.
Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia[J]. J Infect Chemother, 2010,16(3):162-169.
Lai JF, Zindl CL, Duffy LB, et al. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae[J]. PLoS One, 2010, 5(12):e14417.
Kjaer BB, Jensen JS, Nielsen KG, et al. Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood[J]. Pediatr Pulmonol, 2008, 43(6): 567-575.
[11]
Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia[J]. J Infect Chemother, 2010,16(2):78-86.
[12]
Zhang B, Chen ZM. Changes in clinical manifestations of Mycoplasma pneumoniae pneumonia in children older than 3 years during 2000-2006 in Hangzhou[J]. Zhonghua Er Ke Za Zhi, 2010,48(7):531-534.
[13]
Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children[J]. J Antimicrob Chemother, 2011,66(4):734-737.
